Chief Executive of Vectura Group to step down


Chris Blackwell will leave the company on 30 June 2015

After 12 years with Vectura, a UK-based developer of products to treat airways related diseases such as asthma and chronic obstructive pulmonary disease (COPD), Chris Blackwell will step down as Chief Executive on 30 June.

Sign up for your free email newsletter

Blackwell, who joined the company before the Initial Public Offering (IPO) and will assist the Board in the search for his successor, feels that 'now is the right time to move on'.